Clinical efficacy and safety of magnetic sphincter augmentation (MSA) and transoral incisionless fundoplication (TIF2) in refractory gastroesophageal reflux disease (GERD): a systematic review and meta-analysis

Abstract

Background and study aims Proton pump inhibitors (PPI) are effective medical therapy options for gastro-esophageal reflux disease (GERD). However, 20 % to 40 % of patients report symptoms despite taking daily PPI. Transoral incisionless fundoplication (TIF2) and magnetic sphincter augmentation (MSA) are less invasive options for the treatment of refractory GERD and are increasingly gaining popularity.

Methods We conducted a comprehensive search of several databases to identify relevant studies. Our primary aim was to compare the efficacy of both interventions reported as improvement in Gastroesophageal Reflux Disease-Health Related Quality of Life (GERD-HRQL) score, overall patient satisfaction, improvement in post-procedure regurgitation, and fraction of patients completely off PPI therapy at follow up.

Results Twenty-four studies with 1942 patients were included in the final analysis. Both MSA and TIF2 had comparable technical success and clinical success based on improvement in GERD-HRQL scores i. e. 98.8 % (CI 95.6,99.7) vs 98.5 % (CI 95.7,99.5) and 80.4 % (CI 66,89.6) vs 77.7 % (CI 64.1,87.2), respectively. A significantly greater proportion of patients reported improvement in regurgitation, i. e. 91.1 % (CI 83.8,95.3) vs 73.1 % (CI 62.5,81.7) and were able to completely discontinue PPI therapy with MSA compared to TIF2 i. e. 91.3 % (CI 81.5,96.2) vs 63.8 % (CI 51.6,74.4). Patients’ BMI and presence of a hiatal hernia did not have any effect on procedural outcomes.

Conclusion Both procedures performed at par when comparing clinical success in terms of improvement in GERD-HRQL scores. In terms of overall patient satisfaction, post procedure regurgitation and cumulative number of patients off PPI therapy, MSA outperforms TIF2.

Publikationsverlauf

Eingereicht: 21. Juli 2020

Angenommen: 09. Dezember 2020

Artikel online veröffentlicht:
13. April 2021

• References

• 1 Kethman WHM. New approaches to gastroesophageal reflux disease. J Gastrointest Surg 2017; 21: 1544-1552
• 2 Huang X, Chen S, Zhao H. et al. Efficacy of transoral incisionless fundoplication (TIF) for the treatment of GERD: a systematic review with meta-analysis. Surg Endosc 2017; 31: 1032-1044
• 3 Moraes-Filho JP. Refractory gastroesophageal reflux disease. Arq Gastroenterol 2012; 49: 296-301
• 4 Kahrilas PJ, Howden CW, Hughes N. Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease. Am J Gastroenterol 2011; 106: 1419-1425 quiz 1426
• 5 Sheen E, Triadafilopoulos G. Adverse effects of long-term proton pump inhibitor therapy. Dig Dis Sci 2011; 56: 931-950
• 6 Hunter JG, Trus TL, Branum GD. et al. A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease. Ann Surg 1996; 223: 673-685 discussion 685-677
• 7 Minjarez RC, Jobe BA. Surgical therapy for gastroesophageal reflux disease. GI Motility online 2006;
• 8 Singhal T, Balakrishnan S, Hussain A. et al. Management of complications after laparoscopic Nissen's fundoplication: a surgeon's perspective. Ann Surg Innov Res 2009; 3: 1
• 9 Smith CD, McClusky DA, Rajad MA. et al. When fundoplication fails: redo?. Ann Surg 2005; 241: 861-869 discussion 869–871
• 10 Reynolds JL, Zehetner J, Wu P. et al. Laparoscopic Magnetic sphincter augmentation vs laparoscopic Nissen fundoplication: a matched-pair analysis of 100 patients. J Am Coll Surg 2015; 221: 123-128
• 11 Zadeh J, Andreoni A, Treitl D. et al. Spotlight on the Linx™ Reflux Management System for the treatment of gastroesophageal reflux disease: evidence and research. Medical devices (Auckland, NZ) 2018; 11: 291
• 12 Testoni PA, Vailati C, Testoni S. et al. Transoral incisionless fundoplication (TIF 2.0) with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcome. Surg Endosc 2012; 26: 1425-1435
• 13 Trad KS, Barnes WE, Simoni G. et al. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical Trial. Surg Innov 2015; 22: 26-40
• 14 Stroup DF, Berlin JA, Morton SC. et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012
• 15 Ihde GM, Besancon K, Deljkich E. Short-term safety and symptomatic outcomes of transoral incisionless fundoplication with or without hiatal hernia repair in patients with chronic gastroesophageal reflux disease. Am J Surg 2011; 202: 740-746 discussion 746–747
• 16 Ihde GM, Pena C, Scitern C. et al. pH Scores in Hiatal repair with transoral incisionless fundoplication. JSLS 2019; 23: e2018.00087
• 17 Janu P, Shughoury AB, Venkat K. et al. Laparoscopic hiatal hernia repair followed by transoral incisionless fundoplication with EsophyX device (HH + TIF): efficacy and safety in two community hospitals. Surg Innov 2019; 26: 675-686
• 18 Buckley FP, Bell RCW, Freeman K. et al. Favorable results from a prospective evaluation of 200 patients with large hiatal hernias undergoing LINX magnetic sphincter augmentation. Surg Endosc 2018; 32: 1762-1768
• 19 Czosnyka NM, Buckley FP, Doggett SL. et al. Outcomes of magnetic sphincter augmentation – A community hospital perspective. Am J Surg 2017; 213: 1019-1023
• 20 Rona KA, Tatum JM, Zehetner J. et al. Hiatal hernia recurrence following magnetic sphincter augmentation and posterior cruroplasty: intermediate-term outcomes. Surg Endosc 2018; 32: 3374-3379
• 21 Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603-605
• 22 Schwameis K, Nikolic M, Morales Castellano DG. et al. Results of magnetic sphincter augmentation for gastroesophageal reflux disease. World J Surg 2018; 42: 3263-3269
• 23 Bell RC, Barnes WE, Carter BJ. et al. Transoral incisionless fundoplication: 2-year results from the prospective multicenter U.S. study. Am Surg 2014; 80: 1093-1105
• 24 Barnes WE, Hoddinott KM, Mundy S. et al. Transoral incisionless fundoplication offers high patient satisfaction and relief of therapy-resistant typical and atypical symptoms of GERD in community practice. Surg Innov 2011; 18: 119-129
• 25 Stefanidis G, Viazis N, Kotsikoros N. et al. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy. Dis Esophagus 2017; 30: 1-8
• 26 Bell R, Lipham J, Louie B. et al. Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial. Gastrointest Endosc 2019; 89: 14-22.e11
• 27 Hunter JG, Kahrilas PJ, Bell RC. et al. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial. Gastroenterology 2015; 148: 324-333.e325
• 28 Trad KS, Barnes WE, Prevou ER. et al. The TEMPO trial at 5 years: transoral fundoplication (TIF 2.0) is safe, durable, and cost-effective. Surg Innov 2018; 25: 149-157
• 29 Louie BE, Smith CD, Smith CC. et al. Objective evidence of reflux control after magnetic sphincter augmentation: one year results from a post approval study. Ann Surg 2019; 270: 302-308
• 30 Riegler M, Schoppman SF, Bonavina L. et al. Magnetic sphincter augmentation and fundoplication for GERD in clinical practice: one-year results of a multicenter, prospective observational study. Surg Endosc 2015; 29: 1123-1129
• 31 Wilson EB, Barnes WE, Mavrelis PG. et al. The effects of transoral incisionless fundoplication on chronic GERD patients: 12-month prospective multicenter experience. Surg Laparosc Endosc Percutan Tech 2014; 24: 36-46
• 32 Glenny AM, Altman DG, Song F. et al. Indirect comparisons of competing interventions. Health Technol Assess 2005; 9(26): 1-134 iii-iv
• 33 DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188
• 34 Sutton AJ AK, Jones DR. et al. Methods for meta-analysis in medical research. New York: J Wiley; 2000
• 35 Higgins JP, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc 2009; 172: 137-159
• 36 Mohan BP, Adler DG. Heterogeneity in systematic review and meta-analysis: how to read between the numbers. Gastrointest Endosc 2019; 89: 902-903
• 37 Higgins JP, Thompson SG, Deeks JJ. et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560
• 38 Duval S, Tweedie R. Trim and fill: a simple funnel-plot–based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 455-463
• 39 Rothstein HR, Sutton AJ, Borenstein M. Publication bias in meta-analysis: Prevention, assessment and adjustments. John Wiley & Sons; 2006
• 40 Asti E, Bonitta G, Lovece A. et al. Longitudinal comparison of quality of life in patients undergoing laparoscopic Toupet fundoplication versus magnetic sphincter augmentation: Observational cohort study with propensity score analysis. Medicine (Baltimore) 2016; 95: e4366
• 41 Ganz RA, Edmundowicz SA, Taiganides PA. et al. Long-term outcomes of patients receiving a magnetic sphincter augmentation device for gastroesophageal reflux. Clin Gastroenterol Hepatol 2016; 14: 671-677
• 42 Smith CD, DeVault KR, Buchanan M. Introduction of mechanical sphincter augmentation for gastroesophageal reflux disease into practice: early clinical outcomes and keys to successful adoption. J Am Coll Surg 2014; 218: 776-781
• 43 Reynolds JL, Zehetner J, Nieh A. et al. Charges, outcomes, and complications: a comparison of magnetic sphincter augmentation versus laparoscopic Nissen fundoplication for the treatment of GERD. Surg Endosc 2016; 30: 3225-3230
• 44 Warren HF, Reynolds JL, Lipham JC. et al. Multi-institutional outcomes using magnetic sphincter augmentation versus Nissen fundoplication for chronic gastroesophageal reflux disease. Surg Endosc 2016; 30: 3289-3296
• 45 Toomey P, Teta A, Patel K. et al. Transoral incisionless fundoplication: is it as safe and efficacious as a Nissen or Toupet fundoplication?. Am Surg 2014; 80: 860-867
• 46 Rinsma NF, Smeets FG, Bruls DW. et al. Effect of transoral incisionless fundoplication on reflux mechanisms. Surg Endosc 2014; 28: 941-949
• 47 Håkansson B, Montgomery M, Cadiere GB. et al. Randomised clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERD. Aliment Pharmacol Ther 2015; 42: 1261-1270
• 48 Hoppo T, Immanuel A, Schuchert M. et al. Transoral incisionless fundoplication 2.0 procedure using EsophyX™ for gastroesophageal reflux disease. J Gastrointest Surg 2010; 14: 1895-1901
• 49 Petersen RP, Filippa L, Wassenaar EB. et al. Comprehensive evaluation of endoscopic fundoplication using the EsophyX™ device. Surg Endosc 2012; 26: 1021-1027
• 50 Witteman BP, Conchillo JM, Rinsma NF. et al. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease. Am J Gastroenterol 2015; 110: 531-542
• 51 Raza A, Catalano M, Rahimi EF. et al. Efficacy and safety of trans—oral incisionless fundoplication performed by gastroenterologists: 1221. Am J Gastroenterol 2018; 113: S698-S700
• 52 Ebright MI, Sridhar P, Litle VR. et al. Endoscopic Fundoplication: effectiveness for controlling symptoms of gastroesophageal reflux disease. Innovations (Phila) 2017; 12: 180-185
• 53 Testoni PA, Testoni S, Distefano G. et al. Transoral incisionless fundoplication with EsophyX for gastroesophageal reflux disease: clinical efficacy is maintained up to 10 years. Endosc Int Open 2019; 7: E647-E654
• 54 Velanovich V, Vallance SR, Gusz JR. et al. Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg 1996; 183: 217-224
• 55 Fernando HC. Endoscopic fundoplication: patient selection and technique. J Vis Surg 2017; 3: 121
• 56 Guidozzi N, Wiggins T, Ahmed AR. et al. Laparoscopic magnetic sphincter augmentation versus fundoplication for gastroeso112phageal reflux disease: systematic review and pooled analysis. Dis Esophagus 2019; Volume 32, Issue 9, September 2019, doz031
• 57 Chang CG, Thackeray L. Laparoscopic hiatal hernia repair in 221 patients: outcomes and experience. JSLS 2016; 20: e2015.00104